ExodusPoint Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06M	Sell	346,750 -45,051	-11%	-$174K	0.01%	983
2025 Q4	$1.6M	Buy	391,801 +186,564	+91%	+$924K	0.02%	835
2025 Q3	$1M	Buy	205,237 +159,824	+352%	+$839K	0.01%	956
2025 Q2	$230K	Buy	+45,413	New	+$223K	﹤0.01%	1290
2024 Q2	–	Sell	-61,689	Closed	-$615K	–	1943
2024 Q1	$615K	Buy	+61,689	New	+$687K	0.01%	1091
2023 Q2	–	Sell	-31,137	Closed	-$208K	–	2203
2023 Q1	$208K	Buy	+31,137	New	+$247K	﹤0.01%	1568
2022 Q4	–	Sell	-45,832	Closed	-$488K	–	2066
2022 Q3	$488K	Sell	45,832 -146,241	-76%	-$1.48M	0.01%	1379
2022 Q2	$1.56M	Buy	192,073 +158,360	+470%	+$1.06M	0.02%	893
2022 Q1	$241K	Buy	+33,713	New	+$358K	﹤0.01%	1842